Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.
Press releases published on April 22, 2025
CLARENDA “FARMER CEE” STANLEY WINS THE GOOD FARMER AWARD U.S. FROM DAVINES GROUP IN PARTNERSHIP WITH RODALE INSTITUTE
GlobeNewswire
·
April 22, 2025
Kutztown, Penn., April 22, 2025 (GLOBE NEWSWIRE) -- This Earth Day, Davines Group and Rodale Institute are proud to announce Clarenda “Farmer Cee” Stanley as the first-ever recipient of The Good Farmer Award U.S. The award recognizes outstanding farmers …
Oncotelic CEO Vuong Trieu to Present Innovative "Deciparticles" Platform at IDDST-Europe 2025 Conference in Stockholm
GlobeNewswire
·
April 22, 2025
AGOURA HILLS, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC), a biotechnology company focused on nanomedicine and RNA-based therapeutics, announced today that its Chairman and CEO, Dr. Vuong Trieu, will deliver a …
Dental Implants and Prosthetics market to grow at a CAGR of 5.3% during the forecast period (2024 – 2030): Wissen Research
GlobeNewswire
·
April 22, 2025
Sheridan, April 22, 2025 (GLOBE NEWSWIRE) -- According to the latest market report published by Wissen Research, the global dental implants and prosthetics market is projected to be valued at 11.5 billion in 2023. Furthermore, the market is expected to …
U.S. Oral Surgery Management Announces Partnership with Douglas J. Valentine DDS Oral & Maxillofacial Surgery
GlobeNewswire
·
April 22, 2025
IRVING, Texas and GRASS VALLEY, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Management services organization U.S. Oral Surgery Management (USOSM) has secured a new partnership with Douglas J. Valentine DDS Oral …
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs
GlobeNewswire
·
April 22, 2025
LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), an AI-driven precision Medicine Company that leverages AI platforms to improve outcomes for cancer and neurologically challenged patients, today announced is expanding our …
Akari Therapeutics Releases Welcome Video from Newly Appointed Chief Executive Officer, Abizer Gaslightwala
GlobeNewswire
·
April 22, 2025
Biotechnology and pharmaceutical industry veteran, Abizer Gaslightwala, shares his vision for Akari moving forward Access the video here BOSTON and LONDON, April 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company …
Inspirato Announces Partnership with Clean the World to Enhance Sustainability Initiatives
GlobeNewswire
·
April 22, 2025
DENVER, April 22, 2025 (GLOBE NEWSWIRE) -- Inspirato Incorporated (NASDAQ: ISPO), the premier luxury vacation club, is excited to announce its partnership with Clean the World, a global leader in hospitality recycling solutions. This collaboration …
BioProcess360 Partners Launches New Chromatography Company Through Transfer of IP, Assets and Personnel from LigaTrap Technologies
GlobeNewswire
·
April 22, 2025
RALEIGH, N.C., April 22, 2025 (GLOBE NEWSWIRE) -- BioProcess360 Partners today announced the formation of ChromaGenix, a new biotechnology company focused on advancing downstream purification technologies for emerging biotherapeutics. The company has been …
BioProcess360 Partners gründet neues Chromatographie-Unternehmen durch Transfer von IP, Vermögenswerten und Personal von LigaTrap Technologies
GlobeNewswire
·
April 22, 2025
RALEIGH, North Carolina, April 22, 2025 (GLOBE NEWSWIRE) -- BioProcess360 Partners gab heute die Gründung von ChromaGenix bekannt, einem neuen Biotechnologieunternehmen, das sich auf die Entwicklung nachgeschalteter Aufreinigungstechnologien für neue …
BioProcess360 Partners lance une nouvelle société de chromatographie grâce au transfert de propriété intellectuelle, d'actifs et de personnel de LigaTrap Technologies
GlobeNewswire
·
April 22, 2025
RALEIGH, Caroline du Nord, 22 avr. 2025 (GLOBE NEWSWIRE) -- BioProcess360 Partners a annoncé aujourd'hui la création de ChromaGenix, une nouvelle société de biotechnologie axée sur le développement de technologies de purification en aval pour les …
Marius Pharmaceuticals Welcomes John "Shrek" Mcphee as Kyzatrex® (testosterone undecanoate) CIII Capsules Patient Ambassador
GlobeNewswire
·
April 22, 2025
RALEIGH, N.C., April 22, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, announces its partnership with John “Shrek” McPhee, widely recognized in tactical and …
Oncologists invited to RSVP for the 13th Annual Giants of Cancer Care Awards Ceremony honoring oncology leaders
GlobeNewswire
·
April 22, 2025
CRANBURY, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- OncLive invites physicians and oncology professionals to attend the 13th Annual Giants of Cancer Care® Awards Ceremony, an evening dedicated to celebrating visionary achievements in oncology. The …
Digital Dental Lab Dandy Appoints Head of Engineering to Lead Next Wave of AI-Powered Design and Manufacturing
GlobeNewswire
·
April 22, 2025
NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Dandy, the leading fully digital dental lab, has named Cong Yu its new Head of Engineering. Yu brings decades of experience: most recently, he served as VP of Engineering at Celonis, where he built and led the …
Trethera To Participate in Panel Discussion and Research Poster Competition At Los Angeles Bioscience Ecosystem Summit 2025
GlobeNewswire
·
April 22, 2025
LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announces a forthcoming panel discussion and poster …
Nerve Freedom Reviews [Investigated Complaints] Nerve Alive Best Neuropathy Supplement for Nerve Pain Relief Naturally
GlobeNewswire
·
April 22, 2025
LAKELAND, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- Introduction to Nerve Freedom! Nerve Pain often referred to as neuropathy — is one of the most frustrating and debilitating conditions a person can endure. Whether it manifests as a tingling sensation, …
Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey
GlobeNewswire
·
April 22, 2025
In a survey representative of the general U.S. adult population, 1.26 percent of respondents – equivalent to about 3 million people – reported having received a medical diagnosis of babesiosis during their life-time; CDC data imply only about 73,000 people …
科兴控股生物技术有限公司管理层关于审计师辞职的声明
GlobeNewswire
·
April 22, 2025
北京, April 22, 2025 (GLOBE NEWSWIRE) -- 致科兴控股生物技术有限公司全体股东及各利益相关方： 科兴控股生物技术有限公司（纳斯达克股票代码：SVA，以下简称 “公司”）的管理层近日收到公司外部审计师的通知，审计师已决定辞去公司2024 财年年终审计师职务。 根据审计师的辞职信，审计师的辞职决定源于公司现任董事会于2025年4月1 …
Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting
GlobeNewswire
·
April 22, 2025
IRVINE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) will present four distinct data sets highlighting the global prevalence and real-world patient burden of Demodex blepharitis, as well as the impact of XDEMVY® ( …
AP Biosciences Doses First Patient in Phase 1/2 Clinical Trials of AP402 for HER2+ Cancer Patients
GlobeNewswire
·
April 22, 2025
TAIPEI, Taiwan, April 22, 2025 (GLOBE NEWSWIRE) -- AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through development of innovative bispecific antibodies, today announced that it has dosed the first …
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call
GlobeNewswire
·
April 22, 2025
MALVERN, Pa., April 22, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, …